Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa severely impacts quality of life, especially with severe symptoms and certain comorbidities, and current treatments don't significantly improve it.

Psychological therapies may improve quality of life for people with alopecia areata.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

SII is a useful and affordable tool to assess and monitor alopecia areata.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Hair loss significantly affects emotional and social well-being.

Iron deficiency causes many symptoms, and transferrin saturation is a better diagnostic marker than hemoglobin.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

A reliable severity score for female pattern hair loss was developed and validated.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

The tool to measure life quality for women with alopecia is reliable and accurate.

Patients with Alopecia Areata often have higher anxiety and depression.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

A new tool can predict hair regrowth in patchy alopecia areata patients.